Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The malignant external otitis is a rare disease which arises more frequently at the elderly and the diabetics patients. To our knowledge, there are few data and it is not wellc known byclinicians. Nevertheless it exposes to neurological complications potentially serious and crippling.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Necrotizing external otitis | description of necrotizing external otitis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| necrotizing external otitis | Other | description of necrotizing external otitis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Rate of necrotizing external otitis | description of necrotizing external otitis: patients, profile of the bacterium, medical and chirurgical treatment, rate | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of Treatment Failure | Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin. Analyse of risk factor. | Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |
| Duration of antibiotics |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patients having had necrotizing external otitis and managed at the Lyon Bone and joint infection refence Center between 01/01/2006 and 31/01/2018
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tristan Ferry, Md, PhD | Hospices Civils de Lyon | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospices Civils de Lyon | Lyon | 69004 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010031 | Otitis |
| ID | Term |
|---|---|
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Description of the strategies of antibiotic treatments used (double-agent therapy, monotherapy, duration) |
| Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption |